teriparatide

AssetPeptideAlso Teriparatide (rDNA origin), EBP05, EnteraBio's Oral Parathyroid Hormone (1-34), Teriparatide (PF708)

Recombinant parathyroid hormone receptor agonist promoting bone formation

Stage: Approved
Modality: Peptide
Target: PTH1R
Indications: 15
Trials: 81
Developers: 5

Indications

15

Fractures
Approvedaccessdata.fda.gov7 Oct 2026
Hip fracture
Approvedema.europa.eu7 Oct 2026
Osteoporosis
Approvedaccessdata.fda.gov7 Oct 2026

12 more

Targets and what it contains2
Owner and partners5
Trials81
Evidence for its targets2
Competitors3
Signals1

Every asset’s record: target, stage, trials and the evidence behind it.

Updated 7 Oct 2026 · 33 sources